- Display 15 Products per page
Out-of-Pocket Spending in Healthcare (Pharmaceuticals, Surgeries, Tests, Electives, Premiums, Copays, Doctor Visits, Other), 6th Edition
Published: July 13, 2023 | Price: $3,750.00 – $7,500.00
A variety of demographic, business, and government trends are contributing to rising out-of-pocket (OOP) healthcare expenses in the United States. Out-of-Pocket Healthcare Expenditures in the United States, 6th Edition examines these trends in detail, focusing on the financial aspects of OOP spending growth and quantifying the growth of OOP spending with forecasts of total expenditures and specialized healthcare financing. Total Expenditures The report examines past, current, and future levels of U.S. out-of-pocket healthcare expenditures both in total and as specific sub-groups (by type,...
Needle-Free Drug Injection Systems and Safety Syringes: The Market for Alternatives to Traditional Needle-Based Delivery
Published: February 18, 2006 | Price: $2,200.00 – $5,990.00
Biopharmaceutical research and development is sure to dramatically increase the number of injectable drugs coming to market over the next few years. While advanced drug delivery techniques continue to hold promise for unique methods of administration, the traditional injection is still the dominant paradigm. However, the staggering costs and intransigent safety problems associated with sharps, along with consumer demand and the move to alternate-site care, are pushing for alternatives to traditional needles and syringes faster than advanced delivery technologies can...
Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in ‘Theranostics’ and Personalized Medicine)
Published: June 1, 2008 | Price: $2,995.00 – $5,990.00
This Kalorama Information report, Companion Diagnostics Markets (A Realistic Assessment of the Opportunities, Challenges, Key Players and Important Trends in Personalized Medicine) is truly a real-world guide to the potential market for companion diagnostics. Essentially the co-development of testing products to enhance the value and efficacy of a therapeutic, companion diagnostics is widely seen as an important growth strategy in both the diagnostic and pharmaceutical industries. It is envisioned as a pathway to personalized medicine, where the right therapeutic is...
Companion Diagnostics Markets: Forecasts to 2018 (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others)
Published: August 8, 2014 | Price: $995.00 – $1,990.00
Companion Diagnostics Markets (Cancer, Cardiovascular and Blood, Metabolic, Infection, Neurological, Others) Companion drug/test products are of great interest to pharmaceutical companies, testmakers, as well as investors and entrpreneurs. The global market is increasing, and test/product development is increasing as an area of development for pharma companies. Many companion products are now successfully marketed, especially for cancer treatment. Several are part of routine diagnostic and treatment. This report explains events in the market and provides lists of companion products. It also...
The IVD Market in Vietnam: Forecasts to 2019
Published: August 19, 2015 | Price: $1,995.00 – $3,990.00
The IVD Market in Vietnam presents current analysis of the Vietnamese IVD industry. Vietnam has demonstrated fast economic growth in recent years. Increases in foreign investment, wages, trade, industrialization and tourism have led to economic growth higher than that of many other economies in Asia. As a result, IVD companies searching for emerging market areas to pursue growth that is no longer possible in developed nations have targeted Vietnam. The report takes an in-depth look at the market, providing data...
Long Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living
Published: June 1, 2010 | Price: $3,995.00 – $7,990.00
Kalorama Information publishes its third edition of this detailed report on the long term care industry at a time of growth but also change and concern for the long term care industry. The economy has challenged the business strategies of key players, while the recent healthcare legislation introduces changes that may affect revenues. These twin challenges are addressed in The Long-Term Care Market: Nursing Homes, Home Care, Hospice Care, and Assisted Living The report provides an in-depth examination of the...
Pharmaceutical Outsourcing Post-Launch : Contract Manufacturing, Biomanufacturing and Sales, 3rd Edition
Published: January 1, 2009 | Price: $995.00 – $7,000.00
This report is focused on two expanding pharmaceutical outsourcing markets, contract manufacturing of prescription drugs and contract sales and marketing. Both markets represent excellent post launch outsourcing opportunities for companies competing in this fast growing pharmaceutical outsourcing sector. A major factor driving the upward trend in the number of manufacturing projects being outsourced is that specialized production, i.e., sterile manufacturing, biopharmaceutical manufacturing and specialized processes, such as chiral chemistry and improvements in catalyst activity, is often not included in the...
H1N1 “Swine Flu” Vaccine Market Review (Revenues, Forecasts, Lessons for Future Pandemic Vaccines)
Published: May 1, 2010 | Price: $500.00 – $2,400.00
The H1N1 flu epidemic created a public health emergency in 2009. It also created an opportunity for vaccine manufacturers to demonstrate that working with governments of the US and countries around the world, they could manufacture and distribute a vaccine for the virus strain that may have had an impact in reducing cases and deaths. Who were the companies that performed best in this market? How did goverment contracts play out? Most importantly, what are lessons for future pandemic and...
The World Market for Neurotherapeutic Drugs
Published: September 1, 2005 | Price: $3,500.00 – $7,000.00
Management of both acute and chronic neurologic diseases can be challenging for both the patient and the health care provider. Many neurologic disorders involve progressive deterioration in physical and mental capabilities, which can be devastating to the patient and the patient’s family. In many respects, neurotherapeutics represent the largest as-yet untapped market in medicine. This Kalorama Information report focuses on several key product segments of neurotherapeutic treatment: Alzheimer’s Disease and Other Dementias Brain and Neurologic Cancers Brain Trauma and Stroke...
Worldwide Facial Rejuvenation Markets, 4th Edition ( Topical Rejuvenation Products, Fillers and Botulism Products, Laser Resurface, Tumescent Liposuction Products, Chemical Peel, Dermabrasion, Microdermabrasion, Surgical Restoration )
Published: January 17, 2013 | Price: $2,500.00 – $5,000.00
Facial rejuvenation covers a wide range of product and service markets involving the treatment of the effects of aging on the human face. Products such as Botox® and derma fillers, equipment such as lasers and photodynamic therapy systems and services such as chemical peels and microbrasions are covered. and The aging of the population, namely the baby boomer demographic segment is driving the market. The size and wealth of this aging segment and its overwhelming desire to retain a youthful...
Biotech Funding Deals and Partnerships: Analysis of Recent Venture Capital and Corporate Capital Funding and Other Transactions
Published: May 20, 2014 | Price: $995.00 – $1,990.00
Recent Biotech Funding, Deals and Partnerships Nearly one out of every 8 dollars invested in companies are invested in biotech. Biotech investment has increased significantly in the past few years, and 2013 saw a notable spike. In the last few years, this has resulted in a complex series of deals and transactions, ranging from complete buyouts, to licensing transactions, to a variety of collaborative arrangements. In addition to this influx of corporate capital, biotechnology companies have seen a significant influx...
RFID Opportunities in Healthcare in the U.S.
Published: June 1, 2007 | Price: $1,995.00 – $7,990.00
RFID (Radio Frequency IDentification) technologies are dramatically changing many industries, but as detailed in Kalorama's market research report RFID Opportunities in Healthcare in the U.S., the greatest market for RFID is in healthcare. Hospitals, pharmaceutical companies, nursing homes, and other healthcare entities will benefit from using the technologies to keep track of inventories and patients. What are the best markets within healthcare for RFID? How will benefits outweigh costs? How are these technologies best implemented? Who are the leading providers...
Handhelds in Healthcare: The World Market for PDAs, Smartphones, Tablet PCs, Handheld Monitors & Scanners
Published: July 1, 2010 | Price: $3,500.00 – $7,990.00
This Kalorama Information report - The Global Handheld Healthcare Device Market - focuses on two primary segments of healthcare IT: Patient Monitoring Devices, including: Blood pressure devices Pulse oximeters ECG/EKG monitors Ultrasound Diabetes insulin monitors Prothrombin time monitors TENS Fetal heart monitors Administrative Devices, including: PDA/Smartphones Tablet PCs Inventory/Medication Management Scanners Handheld patient monitoring devices include a wide range of products which provide the benefits of diagnosing, consulting, monitoring and treating patients. Handheld administrative devices include products...
The World Market for Infectious Disease Diagnostic Tests
Published: November 1, 2015 | Price: $3,500.00 – $7,000.00
The World Market for Infectious Disease Diagnostic Tests World Market for Infectious Disease Tests provides detailed market estimates and forecasts for four major areas of infectious disease testing, including identification and antibiotic susceptibility testing, immunoassays, molecular testing and blood screening and subsegments within. POC and home testing markets for infectious disease are also provided. Sales and forecasts of infectious disease reagents are made through to 2019. Emerging products and markets are described; key players and strategies discussed and competitive trends...
EMR 2010 (Market Analysis, ARRA Incentives, Key Players, and Important Trends)
Published: December 1, 2009 | Price: $1,995.00 – $7,000.00
It was less than one year ago that Kalorama Information surveyed the market for electronic medical records. Yet much has changed and the changes may reach into every aspect of healthcare. Since our last report, the U.S. Government has decided to incentivize the use of EMRs through extra Medicare payments, companies have merged and new players - including some well-known corporate giants, have entered the field. What impact have the announcement of ARRA (stimulus) incentives had, if any? What is...